These final results, together with a previous report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,two guidance the notion of targeting ACKR3 as a novel method to modulate the opioid method, which could open up new therapeutic avenues for opioid-sim